BAILEY DON M purchased 153.5% of their position (96.16K shares) of LINEAGE CELL THERAPEUTICS, INC. on the open market
Open‑market purchase worth $100.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/8/2024ACC: 0001493152-24-005510
Director
Since Mar 2019
+96.16K
Net shares
Net buyer
$100.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
96.16K acquired
Non-Derivative Transactions1
Common Shares, no par value
Indirect
Shares
+96.16K
Price / share
$1.04
Trade value
$100K
% of position
153.5%
2/8/2024
62.65K→158.80K
Total
Net shares
+96.16K
Net value
$100K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares, no par value Indirect | 2/8/2024 | P · Purchase | +96.16K | $1.04 | $100K | 153.5% | 62.65K | 158.80K |
| Total | +96.16K | $100K | ||||||
Derivative Transactions0
No derivative transactions reported